Jefferies Starts Moderna (MRNA) at Buy; 'Predict Vaccine Will Get Approved and Large Contracts Come'
Tweet Send to a Friend
(Updated - July 13, 2020 6:06 AM EDT)(updating comment)Jefferies analyst Michael Yee initiates coverage on Moderna (NASDAQ: MRNA) with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
